Hollis Brownstein Research Grant

The Leukemia Research Foundation exclusively funds New Investigator grants for blood cancer research projects that focus on leukemia, lymphoma, multiple myeloma, and/or MDS.

• New Investigators are considered to be within seven (7) years of their first independent faculty-level position at the time the grant would be awarded. Years as a resident physician, fellow physician, or post-doctoral fellow are considered to be training years.
• Investigator must be in an independent faculty-level position at the time the application is submitted.
• Adjustments for career interruptions can be made. These could include, but are not limited to, family leave, military service, major illness or injury. It is the responsibility of the applicant to point out and document such interruptions.
• Applicants are not required to be U.S. citizens and research projects from outside the U.S. are eligible.
• Applicants with a KO8, K23, R00, or R99 grant are eligible and the total grant amount will not be applied toward the $175,000 per year threshold on total direct costs.
• DOE, DOD, NSF, R21, or other grants with less than $175,000 per year in total direct costs are permitted.

Not Eligible:

• Applicants with any active single grant (or multiple grants added together) that total $175,000 or greater in total direct costs per year are not eligible (as noted above, KO8, K23, R00, R99 grant awards are excluded from this total threshold).
• Fellows are not eligible to apply.
• Applicants with NIH RO1 funding, VA Merit Award or equivalent.

• Applicants with career development awards from other national foundations (ACS, ASH, Burroughs Wellcome, Kimmel Scholar, etc.).
• Renewal applications will not be accepted.
• Co-PI’s are not permitted.

Minority applicants are valued members of the research community, vital to its success, and are encouraged to apply.

If you have questions about eligibility, please email Grants@LRFmail.org.